ArticleProceedings of the National Academy of Sciences of the United States of America2022

NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer.

Josefina Doffo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.